A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis — Stella

Home/Interstitial Lung Disease/

View on ClinicalTrials.gov

Recruiting

Back to Interstitial Lung Disease trials

Trial locations(1 site)

China

The First Affiliated Hospital of Shandong First Medical University, Jinan, Shandong

Key details

Sponsor

Qianfoshan Hospital

Enrollment target

~610 participants

Started

July 2023

Primary completion

June 2026

Age range

18 Years – 80 Years

Last updated November 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.